Example ImageÃÀ¸ß÷

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ£¬£¬£¬ £¬£¬£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
News information
ÐÂÎÅ×ÊѶ

World ADC | ÃÀ¸ß÷ÑûÄú¹²¸°µÚ15½ìÊÀ½ç¿¹ÌåÒ©ÎïżÁª´ó»á

2024-10-25
|
»á¼ûÁ¿£º

2024Äê11ÔÂ4ÈÕ-7ÈÕ£¬£¬£¬ £¬£¬£¬ÊÀ½ç¿¹ÌåÒ©ÎïżÁª´ó»á£¨World ADC San Diego£©¼´½«Ê¢´ó¿ªÄ»¡£¡£¡£¡£¡£¡£World ADC´ó»áÊÇÀúÊ·ÓÆ¾ÃµÄ¡¢ADCÁìÓò×î´óÇÒ¾ßȨÍþÐԵĹú¼ÊѧÊõ¾Û»áÖ®Ò»£¬£¬£¬ £¬£¬£¬±¾½ì´ó»á½«¼¯ÖÐչʾ¹ú¼ÊÇ°ÑØADCÑз¢Ï£ÍûºÍÁ¢ÒìÍ»ÆÆ¡£¡£¡£¡£¡£¡£

ÃÀ¸ß÷ÃÀ¹úÍŶӽ«ÁÁÏà´Ë´ÎADCÊ¢»á£¬£¬£¬ £¬£¬£¬Õ¹Ê¾ÃÀ¸ß÷ADCһվʽÑз¢Ð§ÀÍÄÜÁ¦£¬£¬£¬ £¬£¬£¬²¢½«ÔÚÃÀ¸ß÷չλ#512£¬£¬£¬ £¬£¬£¬Í¨¹ýÏÖ³¡Õ¹Ì¨»¥¶¯µÈ·½·¨ºÍÈ«ÇòADCÐÐÒµ´ó¿§¾ÙÐÐÉîÈë½»Á÷ºÍ̽ÌÖ£¬£¬£¬ £¬£¬£¬Ò»Á¬¸³ÄÜÐÐÒµ£¬£¬£¬ £¬£¬£¬¼ÓËÙADCÒ©ÎïÑз¢Àú³Ì¡£¡£¡£¡£¡£¡£

ÃÀ¸ß÷ÔÚADCÁìÓòÉî¸û¶àÄ꣬£¬£¬ £¬£¬£¬ÓµÓÐÂÄÀú¸»ºñµÄ¼¼ÊõÍŶӺͺϳÉÂÄÀú£¬£¬£¬ £¬£¬£¬¹¹½¨Á˸»ºñ¶àÑùµÄADC¿â¡£¡£¡£¡£¡£¡£×èÖ¹2024Äê8Ô£¬£¬£¬ £¬£¬£¬ÃÀ¸ß÷ÒÑÀÖ³ÉÖúÁ¦28¸öADCÒ©Îï»ñÅúÁÙ´²£¬£¬£¬ £¬£¬£¬²¢ÓÐ20+ADCÏîÄ¿ÔÚÑС£¡£¡£¡£¡£¡£»£»£»¶Ó­ÒµÄÚͬÈʽìʱÓë»á½»Á÷£¡

ÃÀ¸ß÷ÑûÄú¹²¸°µÚ15½ìÊÀ½ç¿¹ÌåÒ©ÎïżÁª´ó»á.webp

¿¹ÌåżÁªÒ©ÎAntibody-drug conjugates, ADC£©µÄÈý´óÔª¼þ°üÀ¨£º1¡¢ÌØÒìÐÔ°ÐÏò¿¹Ìå 2¡¢¶¾ËØ (Payload£¬£¬£¬ £¬£¬£¬ÓÐÓÃÔØºÉ) 3¡¢¿ÉÁѽâ/²»¿ÉÁѽâµÄÅþÁ¬×Ó(Linker)¡£¡£¡£¡£¡£¡£ADCÁ¬ÏµÁË¿¹ÌåµÄ°ÐÏòÄÜÁ¦ºÍ¶¾ËصĿ¹Ö×ÁöÄÜÁ¦¡£¡£¡£¡£¡£¡£¿£¿£¿£¿£¿£¿¹ÌåºÍ¶¾ËØÍ¨¹ýLinker¾ÙÐÐÅþÁ¬£¬£¬£¬ £¬£¬£¬ÔÊÐí½«ÌØ¶¨Ò©ÎïµÝËÍÖÁ¿¹Ìå°ÐÏòµÄÖ×Áöϸ°û£¬£¬£¬ £¬£¬£¬Ê¹µÃADC³ÉΪÃû¸±×ÅʵµÄ¡°ÉúÎïµ¼µ¯¡±¡£¡£¡£¡£¡£¡£

ADCÒ©ÎïµÄ¿ª·¢¾ßÓнϸߵļ¼Êõ±ÚÀÝ£¬£¬£¬ £¬£¬£¬ÐèÒª×ÛºÏ˼Á¿°ÐµãµÄºÏÀíÑ¡Ôñ£»£»£»¿¹Ìå¡¢Linker¡¢Ð¡·Ö×ÓÒ©Îï¼°ËüÃÇÖ®¼äµÄºÏÀí×éºÏ£»£»£»¿¹ÌåżÁª¼¼ÊõÒÔ¼°ADCÒ©ÎïµÄÄÍÒ©ÐԵȶà¸öÒòËØ¡£¡£¡£¡£¡£¡£ÆäÖУ¬£¬£¬ £¬£¬£¬°ÐµãµÄÑ¡Ôñ¡¢LinkerµÄÑ¡Ôñ¡¢Å¼Áª¼¼ÊõÒÔ¼°ÁÙ´²Ç°µÄҩЧÆÀ¼ÛµÈ¶¼ÊÇADCÑз¢Àú³ÌÖйØ×¢µÄ½¹µã¡£¡£¡£¡£¡£¡£

ÃÀ¸ß÷¿¹ÌåÒ©ÎïżÁªÎADC£©Ñз¢Ð§ÀÍÆ½Ì¨

ÃÀ¸ß÷ÔÚADCµÄÁÙ´²Ç°Ò»Ì廯Ñо¿¼Æ»®Öƶ©ÖÐÓë¿Í»§ÉîÈë½»Á÷£¬£¬£¬ £¬£¬£¬¿ÆÑÐÖ÷¸É½«Ã¿Ò»¸ö°¸ÀýµÄÌØµãÓë¶àÄêʵսÂÄÀúºÍ¼¼Êõ»ýÀÛÏàÁ¬Ïµ£¬£¬£¬ £¬£¬£¬ÉóÉ÷µØ½«ÓÅÖÊʵÑ鼯»®ÓëЧ¹ûÌá½»µ½¿Í»§ÊÖÉÏ¡£¡£¡£¡£¡£¡£

×èÖ¹ÏÖÔÚ£¬£¬£¬ £¬£¬£¬ÃÀ¸ß÷³Ð½ÓµÄINDÉ걨ÀàÉúÎïÒ©´óÏîÄ¿ÒѾ­100¶àÏ£¬£¬ £¬£¬£¬°üÀ¨µ¥¿¹¡¢Ë«¿¹¡¢¶à¿¹¡¢ADC¡¢²¡¶¾ÒßÃçºÍÈÚºÏÂѰ׵ȡ£¡£¡£¡£¡£¡£×èÖ¹2024Äê8Ô£¬£¬£¬ £¬£¬£¬ÃÀ¸ß÷ÒÑÀÖ³ÉÖúÁ¦28¸öADCÒ©Îï»ñÅúÁÙ´²£¬£¬£¬ £¬£¬£¬²¢ÓÐ20+ADCÏîÄ¿ÔÚÑС£¡£¡£¡£¡£¡£

ÃÀ¸ß÷¿ÉÒÔΪ¿Í»§ÌṩADC PayloadsºÏ³É¡¢ADCÒ©ÎïżÁª¡¢ADCҩЧѧÆÀ¼Û¡¢ADCÒ©´ú¶¯Á¦Ñ§ÆÀ¼ÛºÍADCÇå¾²ÐÔÆÀ¼ÛµÈЧÀÍ¡£¡£¡£¡£¡£¡£

Payload (50+)

DX8951f, SN-38, DM1, DM4, Exatecan, Dxd, MMAE/MMAF, Tubulysin M, PBD dimer, Seco-Duocarmycin MA, PNU159682, Doxorubicin analogµÈ¡£¡£¡£¡£¡£¡£

Linker (200+)

¾ßÓжàÖÖCleavableºÍuncleavable¡¢Ç×Ë®ÐÔºÍÊèË®ÐÔÒÔ¼°ÐÂÐÍLinker£¬£¬£¬ £¬£¬£¬È磺Gly-Gly-Phe-Gly, VC-PAB,  SMCC, N-SMPµÈ¡£¡£¡£¡£¡£¡£

Payload+Linker (30+)

SN-38-PEG-PAB, DXD-GlyGlyPheGly, DXD-VCPABDM1-SMCC, DM1-SPP, DM4-SPDB, MC-VC-PAB-MMAE/MMAF, MC-Val-Ala-PBD, VC-PAB-Dolastatin 10µÈ¡£¡£¡£¡£¡£¡£

ÃÀ¸ß÷ÒÑÍê³É°Ðµã

Her2¡¢Her3¡¢Trop2¡¢Claudin 18.2¡¢CD33¡¢Muc1¡¢FRµÈ¡£¡£¡£¡£¡£¡£

ÂÄÀú¼¯³É¸ßˮƽЧÀÍ

ÃÀ¸ß÷ÓÐ×Å¿ª·¢²¢ÑéÖ¤Õë¶Ô²î±ð°ÐµãÆÊÎöÒªÁìµÄ¸»ºñÂÄÀú£¬£¬£¬ £¬£¬£¬Äܹ»ÓÐÓÃÆ¾Ö¤ÐèÇóÆÊÎö°ÐµãµÄ±í´ïˮƽ¡¢ÒÔ¼°°Ðµã¿É¼°ÐÔ£¬£¬£¬ £¬£¬£¬Îª°ÐµãµÄÑ¡ÔñÌṩ½¨ÉèÐÔÒâ¼û¡£¡£¡£¡£¡£¡£

ÁªÏµÃÀ¸ß÷

ÈçÄúÏ£ÍûÔÚÏÖ³¡ÓëÃÀ¸ß÷ר¼ÒÅöÃæ
»¶Ó­ÁªÏµÃÀ¸ß÷ԤԼ°²ÅÅ

ɨÂëÔÚÏßÁªÏµ.webp

ɨÂëÔÚÏßÁªÏµ
ÁªÏµÓÊÏ䣺marketing@medicilon.com.cn

Ïà¹ØÐÂÎÅ
dzÎö£ºADCÒ©ÎïµÄ¿¹°©Ö®Â·
2019-07-24
ÃÀ¸ß÷ÔÚADCÒ©ÎïÁÙ´²Ç°Ò©Ð§Ñ§¡¢Ò©ÎﶯÁ¦Ñ§¼°Çå¾²ÐÔÆÀ¼ÛÑо¿ÁìÓòÒÑ»ýÀÛÁ˸»ºñµÄʵ¼ùÂÄÀúºÍÉîÖ¿µÄÀíÂÛ»ù´¡¡£¡£¡£¡£¡£¡£ÃÀ¸ß÷ÓÐÐÒ¼ÓÈëÁ˲»ÉÙÓÚ4¸öADCÒ©ÎïµÄÁÙ´²Ç°Ò©Ð§Ñ§¡¢Ò©ÎﶯÁ¦Ñ§¼°Çå¾²ÐÔÆÀ¼ÛÑо¿£¬£¬£¬ £¬£¬£¬ÆäÖÐ3¸öADCÒ©ÎïÑо¿×ÊÁÏÒÑ˳Ëìͨ¹ýNMPAºÍFDAÉóÆÀ£¬£¬£¬ £¬£¬£¬ÁíÍâ1¸ö½«ÔÚ2019ÄêÌá½»NMPAÉóÆÀ¡£¡£¡£¡£¡£¡£
¿¹ÌåÒ©ÎïÑз¢Öв»¿ÉºöÊÓµÄÁÙ´²Ç°Ñо¿
2017-05-26
ÉñÅ©³¢°Ù²ÝΪÖβ¡¾ÈÈË£¬£¬£¬ £¬£¬£¬Ò©ÎïÑз¢ÎªÑ°ÕÒÇå¾²¡¢ÓÐÓá¢ÓÅÖÊ¡¢Îȹ̵ÄÐÂҩΪÈËÀ࿵½¡Ð§ÀÍ¡£¡£¡£¡£¡£¡£Éú³¤¼¸Ç§Ä꣬£¬£¬ £¬£¬£¬¡°²¡¡±ºÍ¡°Ò©¡±Ò»Ö±ÔÚÒ»Ö±µÄ¾ÙÐоºÈü¡£¡£¡£¡£¡£¡£
ÁÙ´²Ç°Ñо¿¹«Ë¾
2015-12-03
ÃÀ¸ß÷ÉúÎïÒ½Ò©ÊÇÒ»¼Ò´ÓÊÂÁÙ´²Ç°Ñо¿Íâ°üЧÀÍ£¨CRO£©µÄ¹«Ë¾£¬£¬£¬ £¬£¬£¬×¨ÃÅΪ¿Í»§Ìṩ¿É¶¨ÖƵÄÁÙ´²Ç°ÊÔÑéЧÀͼƻ®£¬£¬£¬ £¬£¬£¬ÓµÓÐÊ®ÓàÄêÑз¢¼¼ÊõÂÄÀú»ýÀÛ£¬£¬£¬ £¬£¬£¬ÔÚÒ©Îï´úл¡¢Ò©´ú¶¯Á¦Ñ§¡¢Ò©Ð§Ñо¿£¬£¬£¬ £¬£¬£¬ÒÔ¼°¶¾Àíѧ·½ÃæÓÐרҵµÄ֪ʶ¡£¡£¡£¡£¡£¡£
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿